 | |
Prof. Suh Sang-hee
|
 |
|
Guru in the field of avian influenza research, Prof. Suh Sang-hee, of the Dept. of Veterinary Medicine at Chungnam National University, announced on Tuesday that he has developed a human vaccine for HPAI (Highly Pathogenic Avian Influenza) for the first time in South Korea, following the US, the UK, and Japan.
According to the research team led by Prof. Suh, AI human vaccine CNUK-H5N1-08-01 was developed via a gene recombination technique while reducing the toxicity of the strain of H5N1 AI introduced in June 2007 after the approval of WHO (World Heal Organisation) and the US government. The team verified the vaccine by experimenting on ferrets.
South Korea has stockpiled imports of Tamiflu, a flu drug, to brace itself for the spread of avian influenza. However, an increasing number of people are demanding a new vaccine, since highly pathogenic H5N1 AI, which is immune to Tamiflu, appeared in Southeast Asia.
(englishnews@chosun.com )
|
